Eric W Linsley insider trades: Panacos Pharmaceuticals (PANC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 21, 2006 | PANC | ↓ Sell | 48,000 | $7.32 | $351K | Indirect | Feb 23, 2006 (2d) |
| Feb 21, 2006 | PANC | ↓ Sell | 22,494 | $7.48 | $168K | Direct | Feb 23, 2006 (2d) |
| Dec 6, 2005 | PANC | ↓ Sell | 600,000 | $7.50 | $4.5M | Indirect | Dec 7, 2005 (1d) |
| Sep 16, 2005 | PANC | ↓ Sell | 400,000 | $9.91 | $4.0M | Indirect | Sep 16, 2005 (0d) |
| Sep 9, 2005 | PANC | ↓ Sell | 22,676 | $10.76 | $244K | Direct | Sep 13, 2005 (4d) |
| Aug 9, 2005 | VITX | ↓ Sell | 90,918 | $7.55 | $686K | Indirect | Aug 9, 2005 (0d) |
| Aug 9, 2005 | VITX | ↓ Sell | 21,924 | $7.55 | $165K | Direct | Aug 9, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Eric W Linsley's insider trades
Eric W Linsley is a director at Panacos Pharmaceuticals (PANC). Since Aug 9, 2005, Eric has reported no open-market purchases and 7 sales worth $10.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PANC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.